Describe the regimens used for Helicobacter pylori eradication and the principles of testing.
Rationale
Helicobacter pylori is a gram-negative spiral bacterium colonising the gastric mucosa, present in the great majority of duodenal ulcers and most gastric ulcers, and classed as a class I carcinogen for gastric adenocarcinoma and malt lymphoma.
- Eradication cures the ulcer disease, reducing recurrence from about 80% a year to under 5%
- Prevalence in India exceeds 60 to 80%, acquired in childhood and related to crowding and sanitation, though only a minority develop disease
- It survives in acid by producing urease, which splits urea to ammonia and creates an alkaline microenvironment — the basis of the urea breath test and the rapid urease test
Regimens
| Regimen | Composition | Duration and comment |
|---|---|---|
| Standard triple therapy | PPI + clarithromycin + amoxicillin (or metronidazole if penicillin allergic), twice daily | 14 days. Now failing where clarithromycin resistance exceeds 15%, which includes much of India |
| Bismuth quadruple therapy | PPI + bismuth subcitrate + metronidazole + tetracycline | 14 days. Preferred first-line where clarithromycin resistance is high, and the standard salvage regimen |
| Concomitant (non-bismuth quadruple) | PPI + clarithromycin + amoxicillin + metronidazole together | 14 days; higher eradication than triple therapy |
| Levofloxacin-based | PPI + levofloxacin + amoxicillin | Salvage therapy; limited in India by high fluoroquinolone resistance |
| Sequential | PPI + amoxicillin for 5 days, then PPI + clarithromycin + metronidazole for 5 days | Less used now |
CLINICAL PEARL
Every eradication regimen contains an acid suppressant, and it is not there for symptom relief. The antibiotics used — particularly amoxicillin and clarithromycin — are unstable and less active at low pH. Raising the intragastric pH makes them chemically stable and lets them work, and also drives the organism into a dividing state in which beta-lactams can act. The proton pump inhibitor is an essential antibacterial adjuvant, not an add-on.
Indications for Testing and Treating
- Proven peptic ulcer disease, active or previous
- Gastric malt lymphoma — eradication alone induces remission in many early cases, which is remarkable for a lymphoma
- Early gastric cancer after resection, and first-degree relatives of gastric cancer patients
- Uninvestigated dyspepsia in the young without alarm features — the "test and treat" strategy
- Before long-term NSAID or aspirin therapy in patients with an ulcer history
- Unexplained iron deficiency anaemia and idiopathic thrombocytopenic purpura
Testing and Confirmation of Cure
- Non-invasive tests — urea breath test (the most accurate), stool antigen, and serology (which cannot distinguish current from past infection and is unsuitable for confirming cure)
- Invasive tests at endoscopy — rapid urease test, histology, culture with sensitivity testing
- Proton pump inhibitors must be stopped 2 weeks before, and antibiotics 4 weeks before, urea breath or stool antigen testing — they suppress the organism and produce false negatives
- Confirm eradication at least 4 weeks after finishing treatment, by breath or stool antigen test, in all treated patients
Applied Aspects
- Adherence determines success — the regimens involve many tablets and cause nausea, diarrhoea and a metallic taste; explaining that a completed course cures the disease permanently substantially improves completion
- Warn about alcohol with metronidazole, and about bismuth blackening the stools and tongue, or the patient will stop in alarm
- Take a careful previous antibiotic history — prior macrolide or fluoroquinolone exposure for any reason strongly predicts resistance, and should change the regimen chosen
- Clarithromycin-based triple therapy is increasingly inappropriate as first-line in India, given the very high background macrolide and metronidazole use; bismuth quadruple therapy is the more reliable choice
- Do not re-use a failed antibiotic in a salvage regimen, with the exception of amoxicillin, to which resistance remains rare
- Eradication does not always abolish dyspepsia, since functional dyspepsia is common and coexists; patients should be told this in advance to avoid disappointment and repeated courses
All questions in Gastrointestinal & Respiratory Drugs
- Q1Describe the physiology of gastric acid secretion. Classify the drugs used in peptic ulcer and reflux disease with their uses and adverse effects. ★
- Q2Describe the physiology of vomiting. Classify antiemetics and describe the choice of drug in different situations. ★
- Q3Classify laxatives and antidiarrhoeal drugs. Describe the drugs used in inflammatory bowel disease. ★
- Q4Classify the drugs used in bronchial asthma. Describe the stepwise management of chronic asthma and of acute severe asthma. ★
- Q5Describe the drugs used in COPD and cough. Describe the methylxanthines with their interactions and toxicity. ★
- SN1Describe the proton pump inhibitors with their mechanism, uses and adverse effects. ★
- SN2Describe the regimens used for Helicobacter pylori eradication and the principles of testing. ★
- SN3Describe the antiemetics used in chemotherapy-induced nausea and vomiting. ★
- SN4Describe the scientific basis, composition and use of oral rehydration therapy. ★
- SN5Describe theophylline with its mechanism, interactions, toxicity and place in therapy. ★
- SN6Describe the inhalational devices and the inhaled corticosteroids. ★
- SN7Describe the drugs used in hepatic encephalopathy and the principles of prescribing in chronic liver disease.